secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
CIK:        0001823239
Form:       8-K
Filed at:   2025-03-20T23:59:59+00:00
Accession:  0001823239-25-000059
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Maravai LifeSciences guides 2025 revenue $185M-$205M; Q1 revenue $43M-$45M
--------------------------------------------------------------------------

- Full-year 2025 revenue guidance $185M-$205M; Q1 2025 revenue $43M-$45M.
- Adjusted EBITDA excludes interest ($14-16M), D&A ($50-55M), stock-based comp ($45-50M).
- Fully diluted shares ~256M; capex expected $15M-$20M in 2025.
- Guidance excludes impact of potential new acquisitions or unquantified items.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1823239/000182323925000059/0001823239-25-000059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1823239/000182323925000059/mrvi-20250320.htm
  HTML page:      https://secwatch.observer/filing/0001823239-25-000059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer